The PYRIN domain–only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses-Reference-Cited by-同舟云学术

The PYRIN domain–only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses

Published:2014-02-16 Issue:4 Volume:15 Page:343-353
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Khare Sonal,Ratsimandresy Rojo A,de Almeida Lúcia,Cuda Carla M,Rellick Stephanie L,Misharin Alexander V,Wallin Melissa C,Gangopadhyay Anu,Forte Eleonora,Gottwein Eva,Perlman Harris,Reed John C,Greaves David R,Dorfleutner Andrea,Stehlik Christian

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.2829.pdf

Reference56 articles.

1. Martinon, F., Burns, K. & Tschopp, J. The Inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol. Cell 10, 417–426 (2002).

2. Stehlik, C. et al. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J. Immunol. 171, 6154–6163 (2003).

3. Srinivasula, S.M. et al. The PYRIN-CARD protein ASC is an activating adaptor for Caspase-1. J. Biol. Chem. 277, 21119–21122 (2002).

4. Barbalat, R., Ewald, S.E., Mouchess, M.L. & Barton, G.M. Nucleic acid recognition by the innate immune system. Annu. Rev. Immunol. 29, 185–214 (2011).

5. Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. 11, 385–393 (2010).

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammasome components as new therapeutic targets in inflammatory disease;Nature Reviews Immunology;2024-09-09

2. Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders;Molecular Neurobiology;2024-07-23

3. MNDA, a PYHIN factor involved in transcriptional regulation and apoptosis control in leukocytes;Frontiers in Immunology;2024-04-12

4. Identification and characterization of endogenous retroviruses upon SARS-CoV-2 infection;Frontiers in Immunology;2024-04-05

5. Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders;Advanced Drug Delivery Reviews;2024-04